Trade Debtors 更改
AbbVie USD 11.41B 79M 2023-09
Abbott USD 6.17B 152M 2023-06
Amgen USD 7.27B 1.12B 2023-12
AstraZeneca USD 12B 65M 2023-09
BioCryst Pharmaceuticals USD 53.65M 4.02M 2023-09
Bristol-Myers Squibb USD 15.65B 588M 2023-09
Eli Lilly USD 10.36B 1.19B 2023-09
Enanta Pharmaceuticals USD 39.62M 5.19M 2023-09
GlaxoSmithKline GBP 8.87B 1.78B 2023-09
Incyte USD 743.56M 86.29M 2023-12
J&J USD 14.8B 1.98B 2023-09
Merck USD 11.49B 263M 2023-09
Nektar Therapeutics USD 2.2M 869K 2023-09
Novartis USD 280M 9.26B 2023-09
Pfizer USD 15B 1.58B 2023-09
Regeneron Pharmaceuticals USD 5.67B 82.8M 2023-12
Roche Holding CHF 11.36B 560M 2023-06
Takeda JPY 788.07B 37.42B 2023-09
TG Therapeutics USD 39.32M 21.84M 2023-09
Ultragenyx Pharmaceutical USD 79.26M 8.74M 2023-09
Xencor USD 11.29M 43.71M 2023-12



Karyopharm Therapeutics 应收帐款人 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.